Aurigon GmbH

Biotechnology

  • Short facts

    • Manufacturer
  • Year founded 2000
  • 67 Employees (site)
  • Turnover: 5m - <10m EUR

Products/services: Aurigon Life Science is an independent privately-owned contract research institute dedicated to preclinical services for human and veterinary pharmaceuticals, food and chemicals. Aurigon provides a full range of advisory and experimental services in pharmacology, bio-/analytics and toxicology. From early-phase product efficacy and safety evaluation to regulatory toxicology and late-stage pre-marketing testing, we cover all areas of non-clinical drug development.

Basic data

Company

Aurigon GmbH

Street

Planegger Str. 9A

PC / City

81241 München

County

Upper Bavaria

Phone

+49 (0)89 780 7200 10

Fax

not available

Language skills

English

Profile/competences

Core competencies

Aurigon Life Science is an independent contract research organization (CRO) which perfoms preclinical research and development. The main emphasis of the company is the combination of pharmacological studies and toxicological testing in accordance with international and national requirements (BfArM, EMEA, FDA, ICH, OECD, GLP). Aurigon offers an integrated service from strategic planning of the preclincal development continuing with the pharmacological characterisation and toxicological testing of the sponsors substance up to the preparation of expert reports for the legal authorities. This includes a comprehensive range of in house services in the fields of preclinical efficacy and safety testing for biotechnology and pharmaceutical companies and the chemical industry.

Key sectors / sub-sectors

  • Biotechnology: Contract research (CROs) and contract manufacturing (CMOs)
  • Biotechnology: Preclinical development

NACE industries

  • Other research and experimental development on natural sciences and engineering 72.19
  • Research and experimental development on biotechnology 72.11

Certifications / awards

not available

Sales markets - target industries

not available

Sales markets - target countries

not available

Cooperation offers

not available